ACRX - 1.75 Pre-market now at 1.85/1.90 AcelRx's DSUVIA™ Clinical Trial Results Selected as a "Top Abstract" for Oral Presentation at ASA's Annual Meeting - ANESTHESIOLOGY® 2017 http://stockcharts.com/c-sc/sc?s=ACRX&p=D&b=5&g=0&i=t46515622430&r=1508502631594 http://stockcharts.com/c-sc/sc?s=ACRX&p=W&b=5&g=0&i=t09834521090&r=1508502677585